You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cyclin G1 gene

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Skin Health and Quality of Life in Patients Receiving

Not yet recruiting
  • Lung Cancer
  • +7 more
  • EQ-5D-5L questionnaire
  • +2 more
  • Roma, Italy
    Roberto Iacovelli
May 17, 2023

GSTP1 and Other Gene Polymorphisms With Platinum-induced

Not yet recruiting
  • Non-small Cell Lung Cancer
  • GSTP1 A313G （AA）
  • (no location specified)
Nov 16, 2023

Extensive-stage Small-cell Lung Cancer Trial (Trilaciclib, Placebo, Topotecan)

Not yet recruiting
  • Extensive-stage Small-cell Lung Cancer
  • (no location specified)
May 22, 2023

Pancreatic Cancer, Osteosarcoma, MPNST (Malignant Peripheral Nerve Sheath Tumor) Trial in Santa Monica (DeltaRex-G)

Available
  • Pancreatic Cancer
  • +6 more
  • Santa Monica, California
    Sarcoma Oncology Research Center, LLC
Jan 20, 2022

Gene-STEPS: Shortening Time of Evaluation in Paediatric Epilepsy

Recruiting
  • Epilepsy
    • Boston, Massachusetts
    • +3 more
    Oct 11, 2023

    Artemis (DCLRE1C ) Deficient Severe Combined Immunodeficiency Trial in Paris (ARTEGENE drug product)

    Not yet recruiting
    • Artemis (DCLRE1C ) Deficient Severe Combined Immunodeficiency
    • ARTEGENE drug product
    • Paris, France
      Department of Pediatric Immunology, Hematology and Rheumatology
    Sep 26, 2022

    Spastic Paraplegia Type 50 Trial in Toronto (MELPIDA)

    Active, not recruiting
    • Spastic Paraplegia Type 50
    • MELPIDA
    • Toronto, Ontario, Canada
      The Hospital for Sick Children
    Oct 5, 2023

    Slow-Flow Vascular Malformation, Fast-Flow Vascular Malformation, Vascular Malformations Trial in Parkville (Alpelisib,

    Not yet recruiting
    • Slow-Flow Vascular Malformation
    • +17 more
    • Parkville, Victoria, Australia
      The Royal Children's Hospital
    Aug 7, 2023

    Choroideremia Trial in Edmonton (rAAV2.REP1 vector)

    Completed
    • Choroideremia
    • rAAV2.REP1 vector
    • Edmonton, Alberta, Canada
      University of Alberta
    May 16, 2022

    Severe Combined Immunodeficiency, X Linked, Gene Therapy Trial in United Kingdom, United States (autologous CD34+ cell

    Recruiting
    • Severe Combined Immunodeficiency, X Linked
    • Gene Therapy
    • autologous CD34+ cell transduced with G2SCID vector
    • Los Angeles, California
    • +4 more
    Jul 19, 2022

    X-linked Severe Combined Immunodeficiency (XSCID) Trial run by the National Institute of Allergy and Infectious Diseases (NIAID)

    Suspended
    • X-linked Severe Combined Immunodeficiency (XSCID)
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 24, 2022

    SMA Trial in Worldwide (Onasemnogene Abeparvovec-xioi)

    Completed
    Has Results
    • SMA
    • Onasemnogene Abeparvovec-xioi
    • Ghent, Belgium
    • +9 more
    Aug 12, 2022

    Severe Combined Immunodeficiency, X-Linked Trial in London (Lentiviral vector transduced CD34+ cells)

    Recruiting
    • Severe Combined Immunodeficiency, X-Linked
    • Lentiviral vector transduced CD34+ cells
    • London, Greater London, United Kingdom
      Great Ormond Street Hospital for Children NHS Foundation Trust
    Mar 15, 2022

    Non-squamous Non-small-cell Lung Cancer, Stage IV NSCLC, ROS1 Gene Rearrangement Trial in Toronto (Crizotinib)

    Recruiting
    • Non-squamous Non-small-cell Lung Cancer
    • +4 more
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Jan 8, 2023

    Opioid Sensitivity, Individual Difference, Abuse Opioids Trial in Baltimore (Within-subject test of blinded study medication)

    Completed
    Has Results
    • Opioid Sensitivity
    • +2 more
    • Within-subject test of blinded study medication
    • Baltimore, Maryland
      Johns Hopkins University Bayview Medical Campus
    Sep 8, 2021

    Acute Myeloid Leukemia, Relapsed Cancer, Refractory Cancer Trial in Edmonton, Toronto (Enasidenib, Venetoclax)

    Active, not recruiting
    • Acute Myeloid Leukemia
    • +3 more
    • Edmonton, Alberta, Canada
    • +1 more
    Jan 31, 2023

    NSCLC, Non-small Cell Carcinoma, Histiocytic Tumor Trial (BDTX-4933)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • +32 more
    • (no location specified)
    Mar 30, 2023

    GSD1 Trial in Worldwide (DTX401)

    Completed
    Has Results
    • GSD1
    • DTX401
    • steroid regimen
    • Farmington, Connecticut
    • +5 more
    Oct 25, 2022

    BRCA1 Gene Mutation, BRCA2 Gene Mutation, Ovarian Serous Adenocarcinoma Trial in Buffalo, New York (biological, other, drug)

    Active, not recruiting
    Has Results
    • BRCA1 Gene Mutation
    • +5 more
    • Durvalumab
    • +3 more
    • Buffalo, New York
    • +1 more
    Jan 20, 2023

    Cyclin-dependent Kinase Inhibitor 2A on Labor-related Signals

    Not yet recruiting
    • Preterm Labor
      • (no location specified)
      May 9, 2023

      Solid Tumor, Haematological Malignancy, Malignancy Trial in United Kingdom (Entrectinib)

      Recruiting
      • Solid Tumor
      • +10 more
      • Belfast, United Kingdom
      • +25 more
      Mar 14, 2023

      Hormone Receptor Positive Breast Carcinoma, Breast Tumors, Tumors, Breast Trial in Italy (Liquid biopsy and CT scan)

      Recruiting
      • Hormone Receptor Positive Breast Carcinoma
      • +6 more
      • Liquid biopsy and CT scan
      • Bergame, Bergamo, Italy
      • +6 more
      Apr 13, 2023

      Study of Retinal Dystrophies Associated With Rare

      Active, not recruiting
      • Inherited Retinal Degeneration
      • Retinitis Pigmentosa
        • Phoenix, Arizona
        • +23 more
        Jan 24, 2023

        International CDKL5 Clinical Research Network

        Recruiting
        • CDKL5
        • +2 more
        • No intervention.
        • Los Angeles, California
        • +8 more
        Sep 23, 2022

        X-Linked Chronic Granulomatous Disease Trial in Paris (X vivo gene therapy)

        Active, not recruiting
        • X-Linked Chronic Granulomatous Disease
        • X vivo gene therapy
        • Paris, France
          Hôpital Necker Enfants Malades
        May 20, 2021